Gene: IGSF9
Official Full Name: immunoglobulin superfamily member 9provided by HGNC
Gene Summary: Predicted to enable cell-cell adhesion mediator activity. Predicted to be involved in axon guidance; dendrite self-avoidance; and homophilic cell adhesion via plasma membrane adhesion molecules. Predicted to act upstream of or within dendrite development and regulation of synapse organization. Predicted to be located in dendrite and inhibitory synapse. Predicted to be active in axon; glutamatergic synapse; and postsynaptic density membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO16973 | IGSF9 Knockout cell line (HCT 116) | Human | IGSF9 | 1:2~1:4 | Negative | Online Inquiry |
IGSF9 Gene Knockout Cell Lines are a tailored research tool designed for investigating the biological functions and pathways associated with the immunoglobulin superfamily member 9 (IGSF9). These cell lines are engineered to possess a complete knockout of the IGSF9 gene, which is involved in a variety of cellular processes including cell adhesion, signaling, and immune response modulation. By eliminating IGSF9 expression, researchers can observe the effects of its absence on cellular behavior, providing valuable insights into disease mechanisms and the role of IGSF9 in different physiological contexts.
The key function of these knockout cell lines lies in their ability to facilitate loss-of-function studies. By comparing the knockout cells with wild-type counterparts, researchers can elucidate the biochemical and molecular pathways downstream of IGSF9. Mechanistically, these cell lines enable an assessment of changes in gene expression, protein interactions, and cell signaling pathways, which could be pivotal in understanding conditions influenced by IGSF9, such as certain autoimmune diseases or cancer.
The scientific importance of the IGSF9 Gene Knockout Cell Lines extends into both basic and applied research settings. They are an indispensable tool for understanding the role of the IGSF9 protein in cellular processes and examining its involvement in tumorigenesis or immune responses, potentially guiding therapeutic development. Furthermore, their usage in drug screening and biomarker discovery makes them valuable assets in pharmaceutical research.
What sets our IGSF9 Gene Knockout Cell Lines apart from alternatives is the assurance of precision genetic modification, robust performance in various assays, and the comprehensive characterizations provided, which include validation of knockout efficiency and functional integrity. These advantages not only enhance reproducibility but also build upon a foundation of trustworthy data, which is a critical asset in scientific research.
For researchers and clinicians, leveraging the insights from IGSF9 Gene Knockout Cell Lines can lead to breakthroughs in understanding complex biological systems and disease mechanisms. Our commitment to advancing research is underscored by our team's expertise in genetic engineering and cell line development, ensuring that our products meet the highest scientific standards while delivering valuable, data-driven results for the scientific community.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.